nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.169	0.25	CbGbCtD
Metronidazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.118	0.175	CbGbCtD
Metronidazole—CYP2C8—Progesterone—uterine cancer	0.112	0.166	CbGbCtD
Metronidazole—CYP2C9—Progesterone—uterine cancer	0.078	0.116	CbGbCtD
Metronidazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0685	0.102	CbGbCtD
Metronidazole—CYP2C8—Etoposide—uterine cancer	0.05	0.0742	CbGbCtD
Metronidazole—CYP3A4—Progesterone—uterine cancer	0.0454	0.0673	CbGbCtD
Metronidazole—CYP3A4—Etoposide—uterine cancer	0.0203	0.0301	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—uterine cancer	0.0138	0.0205	CbGbCtD
Metronidazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.000622	CcSEcCtD
Metronidazole—Malaise—Etoposide—uterine cancer	0.000202	0.000619	CcSEcCtD
Metronidazole—Dermatitis bullous—Doxorubicin—uterine cancer	0.000202	0.000619	CcSEcCtD
Metronidazole—Vertigo—Etoposide—uterine cancer	0.000201	0.000617	CcSEcCtD
Metronidazole—Leukopenia—Etoposide—uterine cancer	0.0002	0.000615	CcSEcCtD
Metronidazole—Body temperature increased—Dactinomycin—uterine cancer	0.000199	0.000612	CcSEcCtD
Metronidazole—Abdominal pain—Dactinomycin—uterine cancer	0.000199	0.000612	CcSEcCtD
Metronidazole—Loss of consciousness—Etoposide—uterine cancer	0.000197	0.000604	CcSEcCtD
Metronidazole—Ataxia—Epirubicin—uterine cancer	0.000196	0.000601	CcSEcCtD
Metronidazole—Convulsion—Etoposide—uterine cancer	0.000194	0.000595	CcSEcCtD
Metronidazole—Hypertension—Etoposide—uterine cancer	0.000193	0.000593	CcSEcCtD
Metronidazole—Diplopia—Doxorubicin—uterine cancer	0.000193	0.000592	CcSEcCtD
Metronidazole—Osteoarthritis—Doxorubicin—uterine cancer	0.000193	0.000592	CcSEcCtD
Metronidazole—Liver function test abnormal—Epirubicin—uterine cancer	0.000192	0.00059	CcSEcCtD
Metronidazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.00059	CcSEcCtD
Metronidazole—Dry skin—Epirubicin—uterine cancer	0.000191	0.000586	CcSEcCtD
Metronidazole—Chest pain—Etoposide—uterine cancer	0.00019	0.000585	CcSEcCtD
Metronidazole—Abdominal pain upper—Epirubicin—uterine cancer	0.00019	0.000584	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000189	0.000581	CcSEcCtD
Metronidazole—Breast disorder—Epirubicin—uterine cancer	0.000188	0.000578	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000187	0.000576	CcSEcCtD
Metronidazole—Nasopharyngitis—Epirubicin—uterine cancer	0.000186	0.000572	CcSEcCtD
Metronidazole—Hypersensitivity—Dactinomycin—uterine cancer	0.000186	0.000571	CcSEcCtD
Metronidazole—Confusional state—Etoposide—uterine cancer	0.000184	0.000565	CcSEcCtD
Metronidazole—Anaphylactic shock—Etoposide—uterine cancer	0.000183	0.000561	CcSEcCtD
Metronidazole—Infection—Etoposide—uterine cancer	0.000181	0.000557	CcSEcCtD
Metronidazole—Abdominal distension—Epirubicin—uterine cancer	0.000181	0.000556	CcSEcCtD
Metronidazole—Ataxia—Doxorubicin—uterine cancer	0.000181	0.000556	CcSEcCtD
Metronidazole—Asthenia—Dactinomycin—uterine cancer	0.000181	0.000556	CcSEcCtD
Metronidazole—Influenza—Epirubicin—uterine cancer	0.00018	0.000553	CcSEcCtD
Metronidazole—Asthma—Epirubicin—uterine cancer	0.00018	0.000553	CcSEcCtD
Metronidazole—Thrombocytopenia—Etoposide—uterine cancer	0.000179	0.000549	CcSEcCtD
Metronidazole—Eosinophilia—Epirubicin—uterine cancer	0.000178	0.000547	CcSEcCtD
Metronidazole—Liver function test abnormal—Doxorubicin—uterine cancer	0.000178	0.000546	CcSEcCtD
Metronidazole—Skin disorder—Etoposide—uterine cancer	0.000177	0.000545	CcSEcCtD
Metronidazole—Dry skin—Doxorubicin—uterine cancer	0.000177	0.000542	CcSEcCtD
Metronidazole—Hyperhidrosis—Etoposide—uterine cancer	0.000176	0.000542	CcSEcCtD
Metronidazole—Pancreatitis—Epirubicin—uterine cancer	0.000176	0.000542	CcSEcCtD
Metronidazole—Abdominal pain upper—Doxorubicin—uterine cancer	0.000176	0.00054	CcSEcCtD
Metronidazole—Breast disorder—Doxorubicin—uterine cancer	0.000174	0.000535	CcSEcCtD
Metronidazole—Anorexia—Etoposide—uterine cancer	0.000174	0.000534	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000173	0.000533	CcSEcCtD
Metronidazole—Bronchitis—Epirubicin—uterine cancer	0.000173	0.000531	CcSEcCtD
Metronidazole—Diarrhoea—Dactinomycin—uterine cancer	0.000173	0.00053	CcSEcCtD
Metronidazole—Nasopharyngitis—Doxorubicin—uterine cancer	0.000172	0.000529	CcSEcCtD
Metronidazole—Pancytopenia—Epirubicin—uterine cancer	0.000171	0.000525	CcSEcCtD
Metronidazole—Dysuria—Epirubicin—uterine cancer	0.000168	0.000517	CcSEcCtD
Metronidazole—Neutropenia—Epirubicin—uterine cancer	0.000168	0.000517	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—uterine cancer	0.000168	0.000515	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000167	0.000514	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—uterine cancer	0.000167	0.000511	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—uterine cancer	0.000167	0.000511	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—uterine cancer	0.000166	0.00051	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—uterine cancer	0.000165	0.000506	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—uterine cancer	0.000164	0.000504	CcSEcCtD
Metronidazole—Paraesthesia—Etoposide—uterine cancer	0.000164	0.000503	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—uterine cancer	0.000163	0.000501	CcSEcCtD
Metronidazole—Somnolence—Etoposide—uterine cancer	0.000162	0.000498	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—uterine cancer	0.00016	0.000493	CcSEcCtD
Metronidazole—Infestation—Epirubicin—uterine cancer	0.00016	0.000493	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—uterine cancer	0.00016	0.000493	CcSEcCtD
Metronidazole—Vomiting—Dactinomycin—uterine cancer	0.00016	0.000492	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—uterine cancer	0.00016	0.000492	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000159	0.000488	CcSEcCtD
Metronidazole—Rash—Dactinomycin—uterine cancer	0.000159	0.000488	CcSEcCtD
Metronidazole—Decreased appetite—Etoposide—uterine cancer	0.000159	0.000487	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—uterine cancer	0.000158	0.000486	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000158	0.000484	CcSEcCtD
Metronidazole—Fatigue—Etoposide—uterine cancer	0.000157	0.000483	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000157	0.000483	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—uterine cancer	0.000156	0.00048	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—uterine cancer	0.000156	0.00048	CcSEcCtD
Metronidazole—Pain—Etoposide—uterine cancer	0.000156	0.000479	CcSEcCtD
Metronidazole—Constipation—Etoposide—uterine cancer	0.000156	0.000479	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—uterine cancer	0.000156	0.000479	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—uterine cancer	0.000156	0.000479	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—uterine cancer	0.000156	0.000478	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—uterine cancer	0.000156	0.000478	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000155	0.000475	CcSEcCtD
Metronidazole—Sweating—Epirubicin—uterine cancer	0.000154	0.000472	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—uterine cancer	0.000154	0.000472	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000152	0.000467	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000152	0.000466	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—uterine cancer	0.000151	0.000462	CcSEcCtD
Metronidazole—Feeling abnormal—Etoposide—uterine cancer	0.00015	0.000462	CcSEcCtD
Metronidazole—Nausea—Dactinomycin—uterine cancer	0.00015	0.00046	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—uterine cancer	0.00015	0.00046	CcSEcCtD
Metronidazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000149	0.000458	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—uterine cancer	0.000148	0.000456	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—uterine cancer	0.000148	0.000456	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—uterine cancer	0.000148	0.000456	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000147	0.000452	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000146	0.000447	CcSEcCtD
Metronidazole—Urticaria—Etoposide—uterine cancer	0.000145	0.000445	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—uterine cancer	0.000145	0.000444	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—uterine cancer	0.000145	0.000444	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—uterine cancer	0.000144	0.000443	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—uterine cancer	0.000144	0.000443	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—uterine cancer	0.000144	0.000443	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—uterine cancer	0.000144	0.000443	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—uterine cancer	0.000144	0.000443	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—uterine cancer	0.000144	0.000442	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—uterine cancer	0.000143	0.00044	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—uterine cancer	0.000143	0.000439	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—uterine cancer	0.000142	0.000437	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—uterine cancer	0.000142	0.000435	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00014	0.000431	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—uterine cancer	0.000139	0.000428	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—uterine cancer	0.000139	0.000426	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000139	0.000425	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—uterine cancer	0.000136	0.000418	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—uterine cancer	0.000135	0.000413	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—uterine cancer	0.000135	0.000413	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—uterine cancer	0.000134	0.000412	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—uterine cancer	0.000134	0.000411	CcSEcCtD
Metronidazole—Flushing—Epirubicin—uterine cancer	0.000134	0.000411	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—uterine cancer	0.000134	0.00041	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—uterine cancer	0.000133	0.000409	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—uterine cancer	0.000133	0.000407	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—uterine cancer	0.000132	0.000406	CcSEcCtD
Metronidazole—Asthenia—Etoposide—uterine cancer	0.000131	0.000402	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—uterine cancer	0.000131	0.000402	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—uterine cancer	0.000131	0.000401	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—uterine cancer	0.00013	0.0004	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—uterine cancer	0.00013	0.000399	CcSEcCtD
Metronidazole—Pruritus—Etoposide—uterine cancer	0.000129	0.000397	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—uterine cancer	0.000128	0.000394	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—uterine cancer	0.000126	0.000388	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000126	0.000387	CcSEcCtD
Metronidazole—Erythema—Epirubicin—uterine cancer	0.000125	0.000385	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—uterine cancer	0.000125	0.000384	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—uterine cancer	0.000125	0.000382	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—uterine cancer	0.000124	0.000382	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—uterine cancer	0.000124	0.00038	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—uterine cancer	0.000124	0.00038	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—uterine cancer	0.000124	0.000379	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—uterine cancer	0.000123	0.000377	CcSEcCtD
Metronidazole—Back pain—Epirubicin—uterine cancer	0.000121	0.000372	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—uterine cancer	0.000121	0.000371	CcSEcCtD
Metronidazole—Dizziness—Etoposide—uterine cancer	0.000121	0.000371	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—uterine cancer	0.000121	0.00037	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—uterine cancer	0.00012	0.00037	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—uterine cancer	0.00012	0.000369	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—uterine cancer	0.000118	0.000363	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—uterine cancer	0.000117	0.000359	CcSEcCtD
Metronidazole—Vomiting—Etoposide—uterine cancer	0.000116	0.000356	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—uterine cancer	0.000116	0.000356	CcSEcCtD
Metronidazole—Rash—Etoposide—uterine cancer	0.000115	0.000353	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—uterine cancer	0.000115	0.000353	CcSEcCtD
Metronidazole—Headache—Etoposide—uterine cancer	0.000114	0.000351	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—uterine cancer	0.000114	0.000351	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—uterine cancer	0.000114	0.000349	CcSEcCtD
Metronidazole—Malaise—Epirubicin—uterine cancer	0.000113	0.000347	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—uterine cancer	0.000113	0.000346	CcSEcCtD
Metronidazole—Syncope—Epirubicin—uterine cancer	0.000112	0.000345	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—uterine cancer	0.000112	0.000345	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—uterine cancer	0.000112	0.000345	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—uterine cancer	0.000112	0.000343	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—uterine cancer	0.000111	0.00034	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—uterine cancer	0.00011	0.000338	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—uterine cancer	0.000109	0.000336	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—uterine cancer	0.000109	0.000334	CcSEcCtD
Metronidazole—Nausea—Etoposide—uterine cancer	0.000108	0.000333	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—uterine cancer	0.000108	0.000332	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—uterine cancer	0.000107	0.000328	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—uterine cancer	0.000107	0.000328	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000106	0.000326	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—uterine cancer	0.000105	0.000321	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—uterine cancer	0.000104	0.000321	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—uterine cancer	0.000104	0.00032	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—uterine cancer	0.000104	0.000319	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—uterine cancer	0.000104	0.000319	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—uterine cancer	0.000103	0.000317	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—uterine cancer	0.000103	0.000315	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—uterine cancer	0.000102	0.000314	CcSEcCtD
Metronidazole—Oedema—Epirubicin—uterine cancer	0.000102	0.000314	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—uterine cancer	0.000102	0.000313	CcSEcCtD
Metronidazole—Infection—Epirubicin—uterine cancer	0.000102	0.000312	CcSEcCtD
Metronidazole—Shock—Epirubicin—uterine cancer	0.000101	0.000309	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—uterine cancer	0.000101	0.000309	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—uterine cancer	0.0001	0.000308	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—uterine cancer	0.0001	0.000308	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—uterine cancer	0.0001	0.000308	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—uterine cancer	9.94e-05	0.000305	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—uterine cancer	9.89e-05	0.000304	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—uterine cancer	9.88e-05	0.000303	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—uterine cancer	9.88e-05	0.000303	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.81e-05	0.000301	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—uterine cancer	9.75e-05	0.0003	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—uterine cancer	9.66e-05	0.000297	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—uterine cancer	9.55e-05	0.000293	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—uterine cancer	9.47e-05	0.000291	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—uterine cancer	9.47e-05	0.000291	CcSEcCtD
Metronidazole—Infection—Doxorubicin—uterine cancer	9.41e-05	0.000289	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.32e-05	0.000286	CcSEcCtD
Metronidazole—Shock—Doxorubicin—uterine cancer	9.32e-05	0.000286	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—uterine cancer	9.29e-05	0.000285	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—uterine cancer	9.27e-05	0.000285	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—uterine cancer	9.26e-05	0.000284	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—uterine cancer	9.2e-05	0.000282	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—uterine cancer	9.19e-05	0.000282	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—uterine cancer	9.15e-05	0.000281	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—uterine cancer	9.1e-05	0.000279	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—uterine cancer	9.03e-05	0.000277	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—uterine cancer	9.01e-05	0.000277	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—uterine cancer	8.9e-05	0.000273	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—uterine cancer	8.83e-05	0.000271	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—uterine cancer	8.82e-05	0.000271	CcSEcCtD
Metronidazole—Pain—Epirubicin—uterine cancer	8.75e-05	0.000269	CcSEcCtD
Metronidazole—Constipation—Epirubicin—uterine cancer	8.75e-05	0.000269	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.63e-05	0.000265	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—uterine cancer	8.56e-05	0.000263	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—uterine cancer	8.5e-05	0.000261	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—uterine cancer	8.43e-05	0.000259	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—uterine cancer	8.42e-05	0.000258	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—uterine cancer	8.37e-05	0.000257	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—uterine cancer	8.33e-05	0.000256	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—uterine cancer	8.23e-05	0.000253	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	8.17e-05	0.000251	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—uterine cancer	8.16e-05	0.000251	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—uterine cancer	8.13e-05	0.00025	CcSEcCtD
Metronidazole—Pain—Doxorubicin—uterine cancer	8.1e-05	0.000249	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—uterine cancer	8.1e-05	0.000249	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—uterine cancer	8.09e-05	0.000248	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—uterine cancer	8.09e-05	0.000248	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—uterine cancer	7.8e-05	0.00024	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—uterine cancer	7.74e-05	0.000238	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—uterine cancer	7.54e-05	0.000232	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—uterine cancer	7.52e-05	0.000231	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—uterine cancer	7.49e-05	0.00023	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—uterine cancer	7.49e-05	0.00023	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—uterine cancer	7.34e-05	0.000225	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—uterine cancer	7.24e-05	0.000222	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—uterine cancer	7e-05	0.000215	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—uterine cancer	6.98e-05	0.000214	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—uterine cancer	6.79e-05	0.000209	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—uterine cancer	6.77e-05	0.000208	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—uterine cancer	6.7e-05	0.000206	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—uterine cancer	6.51e-05	0.0002	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—uterine cancer	6.48e-05	0.000199	CcSEcCtD
Metronidazole—Rash—Epirubicin—uterine cancer	6.45e-05	0.000198	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—uterine cancer	6.45e-05	0.000198	CcSEcCtD
Metronidazole—Headache—Epirubicin—uterine cancer	6.41e-05	0.000197	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—uterine cancer	6.26e-05	0.000192	CcSEcCtD
Metronidazole—Nausea—Epirubicin—uterine cancer	6.08e-05	0.000187	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—uterine cancer	6.02e-05	0.000185	CcSEcCtD
Metronidazole—Rash—Doxorubicin—uterine cancer	5.97e-05	0.000183	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—uterine cancer	5.96e-05	0.000183	CcSEcCtD
Metronidazole—Headache—Doxorubicin—uterine cancer	5.93e-05	0.000182	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—uterine cancer	5.62e-05	0.000173	CcSEcCtD
